Filing Details

Accession Number:
0001140361-12-008757
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-15 17:17:07
Reporting Period:
2012-02-15
Filing Date:
2012-02-15
Accepted Time:
2012-02-15 17:17:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
69499 Mylan Inc. MYL Pharmaceutical Preparations (2834) 251211621
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197543 J Robert Coury 1500 Corporate Drive
Canonsburg PA 15317
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-15 150,000 $12.38 936,964 No 4 M Direct
Common Stock Disposition 2012-02-15 150,000 $23.25 786,964 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Right to Buy Acquisiton 2012-02-15 150,000 $0.00 150,000 $12.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
391,875 2005-07-22 2012-07-22 No 4 M Direct
Footnotes
  1. As disclosed in the Company's Form 10-Q for the quarter ended September 30, 2011, Mr. Coury's stock options were among those held by directors that were set to expire in 2012.
  2. The reporting person's indirect ownership through 401(k) holdings as of January 17, 2012 was 4,957.
  3. Represents the weighted price of the reporting person's disposition of 150,000 shares in transactions ranging from $23.06 to $23.48 per share.
  4. This option execise was executed in accordance with Mr. Coury's 10b5-1 trading plan dated December 14, 2011.